TERESA LIMLE: Open Payments
NPI 1962280537 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,383 in 137 payments from 13 companies in 2025. Trend: 2023 $293 · 2024 $698 · 2025 $2,383
Food & beverage: $2,375Education: $8
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 21 | $528 |
| Otsuka America Pharmaceutical, Inc. | 17 | $489 |
| Alkermes, Inc. | 9 | $206 |
| Neurocrine BioSciences, Inc. | 12 | $198 |
| Janssen Pharmaceuticals, Inc | 6 | $196 |
| Supernus Pharmaceuticals, Inc. | 37 | $180 |
| ABBVIE INC. | 13 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $103 |
| Teva Pharmaceuticals USA, Inc. | 5 | $90 |
| Lundbeck LLC | 4 | $78 |
Products named: FANAPT, ABILIFY ASIMTUFII, INGREZZA, INVEGA SUSTENNA, ARISTADA, REXULTI, Qelbree, VRAYLAR.
Industry payments across MO — which companies pay providers there.
